Skip to content

BORLOO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BORLOO

BE 0436.617.586
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€19,386
2023 · €23,507-€4,121
Equity
€215,258
2023 · €195,872+€19,386
Cash
€228,183
2023 · €209,706+€18,477
Balance sheet total
€229,836
2023 · €213,713+€16,122

Largest movements

2023 to 2024
Assets
  • Cash +€18,477

    up €18,477 (+8.8%), from €209,706 to €228,183

    mainly Net result for the year (+€19,386) and Receivables within one year (+€1,997)

Equity and liabilities
  • Reserves +€19,386

    up €19,386 (+10.9%), from €177,280 to €196,666

  • Tax, wage and social debts -€3,295

    down €3,295 (-21.2%), from €15,520 to €12,225

Income statement
  • Gross operating margin -€5,647

    down €5,647 (-15.6%), from €36,106 to €30,460

  • Taxes -€1,753

    down €1,753 (-14.9%), from €11,764 to €10,010

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €23,507
Gross operating margin -€5,647
Other operating charges -€228
Financial income -€0
Financial charges -€0
Taxes +€1,753
Result 2024 €19,386

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€18,477
Investment €0
Financing €0
Cash 2023 €209,706
Net result for the year +€19,386
Depreciation +€358
Receivables within one year +€1,997
Trade debts +€290
Tax, wage and social debts -€3,295
Other debts -€259
Cash 2024 €228,183
Every line side by side 33 lines
Line Code 2023 2024 Change %
Total assets 20/58 €213,713 €229,836 +€16,122 +7.5%
Fixed assets 21/28 €716 €358 -€358 -50.0%
Tangible fixed assets 22/27 €716 €358 -€358 -50.0%
Plant, machinery and equipment 23 €716 €358 -€358 -50.0%
Current assets 29/58 €212,998 €229,478 +€16,480 +7.7%
Amounts receivable within one year 40/41 €2,915 €919 -€1,997 -68.5%
Trade receivables 40 €2,915 €919 -€1,997 -68.5%
Cash at bank and in hand 54/58 €209,706 €228,183 +€18,477 +8.8%
Deferred charges and accrued income 490/1 €376 €376 = 0.0%
Total equity and liabilities 10/49 €213,713 €229,836 +€16,122 +7.5%
Equity 10/15 €195,872 €215,258 +€19,386 +9.9%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €177,280 €196,666 +€19,386 +10.9%
Distributable reserves 133 €177,280 €196,666 +€19,386 +10.9%
Amounts payable 17/49 €17,841 €14,578 -€3,264 -18.3%
Amounts payable within one year 42/48 €17,841 €14,578 -€3,264 -18.3%
Trade debts 44 €1,419 €1,709 +€290 +20.4%
Suppliers 440/4 €1,419 €1,709 +€290 +20.4%
Taxes, remuneration and social security 45 €15,520 €12,225 -€3,295 -21.2%
Taxes 450/3 €15,520 €12,225 -€3,295 -21.2%
Other amounts payable 47/48 €903 €644 -€259 -28.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €358 €358 = 0.0%
Other operating charges 640/8 €384 €612 +€228 +59.3%
Gross operating margin 9900 €36,106 €30,460 -€5,647 -15.6%
Operating profit (loss) 9901 €35,364 €29,489 -€5,874 -16.6%
Financial income 75/76B €0 - -€0
Recurring financial income 75 €0 - -€0
Financial charges 65/66B €93 €93 +€0 0.0%
Recurring financial charges 65 €93 €93 +€0 0.0%
Profit (loss) for the period before taxes 9903 €35,271 €29,396 -€5,875 -16.7%
Income taxes 67/77 €11,764 €10,010 -€1,753 -14.9%
Profit (loss) for the period 9904 €23,507 €19,386 -€4,121 -17.5%
Profit (loss) for the period to be appropriated 9905 €23,507 €19,386 -€4,121 -17.5%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.